U.S. Building Stock News

NYSE:S
NYSE:SSoftware

Is There Now An Opportunity In SentinelOne (S) After A 45% One Year Share Price Fall

If you are wondering whether SentinelOne's current share price reflects its true worth, this article will walk through what the numbers are really saying about the stock. After its last close at US$13.40, SentinelOne's returns sit at a 2.4% decline over 7 days, a 3.6% decline over 30 days, an 8.5% decline year to date, and a 45.0% decline over the past year, with a 12.5% decline over 3 years. Recent coverage of SentinelOne has focused on its position in cybersecurity and how investor...
NYSE:PHIN
NYSE:PHINAuto Components

What PHINIA (PHIN)'s Strong 2025 Results and 2026 Outlook Means For Shareholders

In February 2026, PHINIA Inc. reported that fourth-quarter 2025 sales rose to US$889 million with net income of US$45 million, while full-year 2025 sales reached US$3.48 billion and net income climbed to US$130 million, alongside higher diluted earnings per share from continuing operations for both periods versus the prior year. The company also issued 2026 guidance calling for net sales of US$3.52 billion to US$3.72 billion and higher projected net earnings, reinforcing investor attention...
NYSE:FRT
NYSE:FRTRetail REITs

A Look At Federal Realty (FRT) Valuation After Earnings Beat Guidance And Dividend Affirmation

Why Federal Realty Investment Trust (FRT) Is In Focus After Its Latest Earnings Federal Realty Investment Trust (FRT) has drawn fresh attention after reporting fourth quarter and full year 2025 results, issuing 2026 earnings guidance, and affirming regular common and preferred dividends on the same day. See our latest analysis for Federal Realty Investment Trust. The earnings beat, fresh 2026 guidance and confirmation of both common and preferred dividends come as Federal Realty Investment...
NasdaqGM:NTLA
NasdaqGM:NTLABiotechs

Clinical Hold Lift On MAGNITUDE-2 Resets Risk Reward For Intellia Investors

Regulators have lifted the clinical hold on Intellia Therapeutics' MAGNITUDE-2 study, allowing the gene editing trial to resume. The decision follows updates to safety protocols after rare adverse events were evaluated. The cleared pathway enables expanded enrollment for MAGNITUDE-2 and continued work on Intellia's in vivo gene editing program. For you as an investor looking at Intellia Therapeutics (NasdaqGM:NTLA), this regulatory step comes as the stock trades at $12.22. The share price...
NasdaqGS:ROAD
NasdaqGS:ROADConstruction

The Bull Case For Construction Partners (ROAD) Could Change Following Raised 2026 Guidance And Buybacks - Learn Why

Construction Partners, Inc. recently reported first-quarter 2026 results showing sales of US$809.47 million and net income of US$17.21 million, and it raised full-year fiscal 2026 revenue and net income guidance while also completing a US$22.94 million share repurchase program announced in April 2024. Alongside these financial updates, the company’s participation at the Barclays 43rd Annual Industrial Select Conference in Miami in February 2026 gave management an additional platform to...
NYSE:DE
NYSE:DEMachinery

Has Deere (DE) Run Too Far After 29% Year To Date Surge?

Wondering whether Deere at around US$600 a share still offers fair value, or if the price has already run too far ahead of the fundamentals? This article is built to help you answer that question calmly and clearly. The stock last closed at US$600.84, with returns of 1.3% over 7 days, 16.8% over 30 days, 28.7% year to date, 21.4% over 1 year, 46.7% over 3 years, and 90.1% over 5 years. This naturally raises questions about what is already priced in and how much risk is now on the...
NYSE:AB
NYSE:ABCapital Markets

AllianceBernstein Initiatives In Research And Tech Set Against Valuation Concerns

AllianceBernstein Holding (NYSE:AB) has entered a new joint venture with Societe Generale to build out global research capabilities. The firm is expanding further into private alternatives with capital support from EQH. AllianceBernstein has also signed a multi year partnership with SimCorp to upgrade its investment technology and data infrastructure. For investors watching NYSE:AB, these moves sit alongside a recent share price of $41.43 and multi year total returns of 21.9% over 1 year,...
NasdaqCM:ATOM
NasdaqCM:ATOMSemiconductor

A Look At Atomera (ATOM) Valuation After GAA MST Breakthroughs And New OEM Partnership

Atomera (ATOM) is back on investors’ radar after reporting fourth quarter and full year 2025 results that highlight very small current sales, continued losses, and ongoing investment in its Mears Silicon Technology platform. See our latest analysis for Atomera. The latest earnings release and technical updates landed alongside a sharp shift in sentiment, with a 46.17% 1 day share price return and a 142.80% year to date share price return contrasting with a 5 year total shareholder return...
NYSE:STT
NYSE:STTCapital Markets

What State Street (STT)'s New Prime Money Market ETF and Mariner Deal Mean For Shareholders

In February 2026, State Street Corporation announced that Mariner will adopt Charles River’s Wealth Management Solution to support its goal of scaling from more than 2,080 advisors toward 5,000 while centralizing portfolio management, trading, data integration, and advisor workflows. State Street Investment Management also launched the actively managed State Street Prime Money Market ETF (ticker: MMK), a low-cost prime cash vehicle drawing on its cash team’s US$599.55 billion in assets...
NasdaqGS:KLIC
NasdaqGS:KLICSemiconductor

Assessing Whether Kulicke And Soffa (KLIC) Shares Look Overvalued After Their Recent Strong Run

Why Kulicke and Soffa Industries (KLIC) Is On Investors’ Radar Kulicke and Soffa Industries (KLIC) has drawn fresh attention after a strong past 3 months for the stock, with recent trading around $71.77 prompting investors to reassess its valuation and fundamentals. See our latest analysis for Kulicke and Soffa Industries. While the share price is around $71.77 after a 24.71% 1 month share price return and 103.37% 3 month share price return, the 72.18% 1 year total shareholder return suggests...
NasdaqGS:PPC
NasdaqGS:PPCFood

Assessing Pilgrim's Pride (PPC) Valuation After Earnings Miss And 2026 Expansion Plan

Pilgrim's Pride (PPC) is back in focus after reporting fourth quarter 2025 earnings, with higher sales and softer margins, plus a sizable 2026 capex plan aimed at prepared foods capacity and operational efficiencies. See our latest analysis for Pilgrim's Pride. The latest earnings release and 2026 capex plan come after a period of firm momentum in the shares, with a 30 day share price return of 5.10% and a 90 day share price return of 15.61%. This is the case even though the 1 year total...
NYSE:TE
NYSE:TEElectrical

Assessing T1 Energy (TE) Valuation After Sudden Chief Accounting Officer Transition

Why this leadership change at T1 Energy (TE) is on investors’ radar T1 Energy (TE) just made an abrupt change in a key finance role, with the immediate departure of Chief Accounting Officer and Corporate Controller Denise Cruz and the same-day appointment of Tom Mahrer. Because this position oversees accounting policy and financial reporting, any sudden shift can draw investor focus to how the company’s numbers are produced, audited, and communicated to the market. See our latest analysis for...
NasdaqCM:MARA
NasdaqCM:MARASoftware

MARA Holdings Faces Rising Short Interest As Earnings Estimates Improve

Short interest in MARA Holdings (NasdaqCM:MARA) has recently moved sharply higher, now sitting well above levels seen in many peers. Analysts have turned more cautious on the stock, citing sector risks and increased insider selling activity. The shift in positioning comes even as some earnings estimates for MARA Holdings have been revised upward. MARA Holdings, listed on NasdaqCM under the ticker MARA, has attracted fresh attention as investor positioning has turned more bearish. The...
NasdaqGS:TEAM
NasdaqGS:TEAMSoftware

Atlassian Rovo AI And Cloud Gains Contrast With Prolonged Share Price Weakness

Atlassian (NasdaqGS:TEAM) highlighted rapid uptake of its Rovo AI platform in the latest quarter, pointing to expanding use across enterprise customers. The company reported new milestones in cloud revenue alongside this AI adoption, underscoring the role of cloud products in its business mix. Management raised full year guidance following strong quarterly results, signaling that recent operating trends are influencing its outlook for the rest of the year. For investors watching...
NYSE:CRH
NYSE:CRHBasic Materials

Assessing CRH (NYSE:CRH) Valuation As Earnings Approach And A $300 Million Buyback Progresses

Why CRH (NYSE:CRH) is in focus today CRH (NYSE:CRH) heads into its quarterly earnings announcement on February 18, 2026, with investors watching both the profit update and any guidance, while its ongoing $300 million buyback continues through recent 29,600-share repurchases. See our latest analysis for CRH. CRH’s 1-day share price return of a 3.14% decline and 7-day share price return of a 5.52% decline contrast with a stronger 90-day share price return of 10.78% and a 3-year total...
NYSE:TFC
NYSE:TFCBanks

Is Truist’s Mastercard-Powered Open Banking Move Reframing Its Digital Efficiency Story for Investors (TFC)?

In February 2026, Truist Financial Corporation announced its first open banking integration, using Mastercard’s open finance technology to give consumer and small business clients secure, API-based connections to fintech apps with tokenized data access and centralized control. This move highlights how Truist is using partnership-driven technology to enhance client data security and customization while expanding its role in the open finance ecosystem. We’ll now examine how Truist’s...
NYSE:OSCR
NYSE:OSCRInsurance

Assessing Oscar Health’s Valuation As New Credit Facility And 2026 Guidance Reframe Its Outlook

What the new credit facility and 2026 outlook mean for Oscar Health Oscar Health (OSCR) just paired a new US$475 million revolving credit facility with fresh 2026 guidance and full year 2025 results. Together, these provide a clearer view of its balance sheet and earnings ambitions. See our latest analysis for Oscar Health. The new credit facility and 2026 outlook arrive after a mixed year in the market, with a 7 day share price return of 3.96% but a 30 day share price return decline of...
NYSE:DCH
NYSE:DCHAuto Components

Assessing Whether Dauch (DCH) Is Undervalued After Recent Share Price Volatility

Stock performance snapshot and recent context Dauch (DCH) has drawn attention after a period of mixed share performance, with a small 1 day gain of 0.41% contrasting with a roughly 14% decline over the past week. Over the past month the stock shows a decline of about 5%, while the past 3 months are positive at roughly 17%. Year to date, Dauch is up about 12%, with a 1 year total return of around 26%. See our latest analysis for Dauch. The latest 7 day share price return of around 14% decline...
NasdaqCM:EXAS
NasdaqCM:EXASBiotechs

Assessing Exact Sciences (EXAS) Valuation After A Strong Year Of Shareholder Returns

Why Exact Sciences (EXAS) is on investors’ radar Exact Sciences (EXAS) has drawn attention after a period of strong 1 year total return of 108.16% and past 3 months return of 19.88%, prompting closer scrutiny of its current valuation. See our latest analysis for Exact Sciences. At a share price of US$103.31, Exact Sciences has seen a strong 1 year total shareholder return of 108.16%, while its 90 day share price return of 19.88% suggests momentum has recently picked up after a more muted...
NYSE:TROX
NYSE:TROXChemicals

Is It Time To Rethink Tronox Holdings (TROX) After Its Recent Share Price Surge

If you are wondering whether Tronox Holdings at around US$7.60 is a bargain or a value trap, looking closely at how the market is pricing the business is a good place to start. The share price has been volatile recently, with a 32.9% return over the last 30 days, a 78.0% return year to date, but only a 1.7% return over the past year and longer term declines of 41.8% over three years and 54.2% over five years. These swings have put Tronox back on the radar for investors comparing short term...
NYSE:ASAN
NYSE:ASANSoftware

Assessing Asana’s (ASAN) Valuation After Prolonged Share Price Weakness

What recent returns are telling investors about Asana (ASAN) Asana (ASAN) has been on many watchlists after a stretch of weak share performance, with the stock down over the past month, past 3 months, year to date, and over the past year. Those returns, including a 2.6% decline over the past day and double digit drops across recent periods, are prompting investors to look more closely at how Asana’s business metrics line up with its current share price. See our latest analysis for Asana. At a...
NYSE:DELL
NYSE:DELLTech

Dell McLaren AI Push Puts Valuation And Growth Story In Focus

Dell Technologies expanded its partnership with McLaren Racing to supply advanced AI infrastructure and data solutions for Formula 1 operations. The collaboration focuses on AI powered servers, simulation platforms, and data tools to support race strategy, car development, and real time decision making. For investors watching NYSE:DELL, this update highlights how Dell Technologies is positioning its AI and data stack in a demanding, mission critical setting. The company’s shares most...
NYSE:BORR
NYSE:BORREnergy Services

Is Analyst Repricing And Q4 Guidance Shifting The Investment Case For Borr Drilling (BORR)?

Citigroup analyst Scott Gruber recently reiterated a Neutral rating on Borr Drilling and raised its price target, while the company released its Q4 2025 earnings today after previously signaling an expected earnings per share loss of $0.03. These developments highlight how analysts are closely tracking Borr Drilling’s contracting progress and financial outlook as they reassess expectations for its offshore drilling operations across multiple regions. We’ll now examine how the upcoming...
NYSE:BBAI
NYSE:BBAIIT

BigBear.ai Acquisition And Debt Shift Reframe AI Growth Story

BigBear.ai Holdings (NYSE:BBAI) completed its acquisition of Ask Sage, adding new AI capabilities to its platform. The company also carried out a significant debt reduction by converting a portion of its outstanding notes into equity. Together, these moves reshape BigBear.ai’s capital structure and product offering in the AI and data analytics space. BigBear.ai focuses on AI driven decision intelligence and data analytics, serving both government and commercial customers. The Ask Sage...